Back to company

Cortrium ApS: Financial statements 2024

CVR: 36445335

Cortrium ApS (CVR 36445335) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 12,068,659 and a net result of DKK -16,013,406 compared with DKK -13,673,474 the year before. That is an increase of 66.5% compared with the year before. Equity amounted to DKK 11,722,757. The solvency ratio was 48.1%. The company had 30 employees in the financial year.

Gross Profit
12,068,659 kr.
Profit/Loss
-16,013,406 kr.
Equity
11,722,757 kr.
Total Assets
24,367,216 kr.
Employees
30

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-12.1 mio.-16 mio.11.7 mio.30
2023-7.2 mio.-13.7 mio.11.2 mio.30
2022-6.7 mio.-10 mio.-4 mio.23
2021-4.7 mio.-5 mio.499 t.18
2020-1.3 mio.-7.7 mio.487 t.9

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Cortrium ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Cortrium ApS: The 2023 annual report is outJun 26, 2024

Cortrium ApS has published its annual report for 2023. Gross profit came to DKK 7,247,644, and the net result was DKK -13,673,474.

About Cortrium ApS

Cortrium ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named OPEON ApS. The management consists of Philippe Alexandre Wargniez Jørgensen. The company's owners include Lind Family Holding A/S, Zibra A/S and T&W Medical A/S. The company has 8 employees. In 2025, the company reported a gross profit of DKK 11,852,641 and a net result of DKK -23,885,086 compared with DKK -16,013,406 the year before. Equity amounted to DKK 23,893,751.